|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (1997)) |
IUPAC Name ![]() |
| 6-chloro-1-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 4673 | fenoldopam |
Synonyms ![]() |
| Corlopam® |
| SK&F-82526J |
| SK-82526-J |
Database Links ![]() |
|
| BindingDB Ligand | 50020681 |
| CAS Registry No. | 67227-56-9 |
| ChEBI | CHEBI:5002 |
| ChEMBL Ligand | CHEMBL588 |
| DrugBank Ligand | DB00800 |
| PharmGKB Drug | PA164784034 |
| PubChem CID | 3341 |
| Search Google for chemical match using the InChIKey | TVURRHSHRRELCG-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | TVURRHSHRRELCG |
| Search PubMed clinical trials | fenoldopam |
| Search PubMed titles | fenoldopam |
| Search PubMed titles/abstracts | fenoldopam |
| Wikipedia | Fenoldopam |
| Comments |
| The approved drug fenoldopam is a racemic mixture of (+)-SKF-82526 and (-)-SKF-82526 stereoisomers. We show the non-isomeric structure to represent this mixture. Marketed formulations may contain fenoldopam mesylate (PubChem CID 49659). |